Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003833 · ClinicalTrials.gov registry record
Genetic Study in Patients With Stage II or Stage III Colon Cancer
A clinical trial of Colorectal Cancer, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 598
- Enrollment target
- 20
- Study locations
NCT00003833 is a study of Colorectal Cancer that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 598 participants, below the 1,510-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (60% lower). The trial reports 20 study locations across 7 states.
The verdict
NCT00003833, a study of Colorectal Cancer, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 598 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Genetic studies may help in understanding the genetic processes that cause some types of cancer. PURPOSE: Genetic trial to study certain genes of patients who have stage II or stage III colon cancer.
Conditions Studied
Interventions
- GENETIC DNA stability analysis
- GENETIC gene mapping
Study Locations (20)
British Columbia
- Nanaimo Cancer Clinic - Nanaimo
- British Columbia Cancer Agency - Fraser Valley Cancer Centre - Surrey
- Prostate Centre at Vancouver General Hospital - Vancouver
- British Columbia Cancer Agency - Vancouver
- St. Paul's Hospital - Vancouver - Vancouver
- G. Steinhoff Clinical Research - Victoria
Ontario
- Royal Victoria Hospital, Barrie - Barrie
- William Osler Health Centre - Brampton
- Northeastern Ontario Regional Cancer Centre, Sudbury - Greater Sudbury
- Hamilton and District Urology Association - Hamilton
- London Health Sciences Centre - London
New Brunswick
- Moncton Hospital - Moncton
- Doctor Leon Richard Oncology Centre - Moncton
- Saint John Regional Hospital - Saint John
Alberta
- Tom Baker Cancer Center - Calgary - Calgary
- Lethbridge Cancer Clinic - Lethbridge
Nova Scotia
- Nova Scotia Cancer Centre - Halifax
- Cape Breton Cancer Centre - Sydney
Minnesota
- St. Mary's/Duluth Clinic Health System - Duluth
Newfoundland and Labrador
- Newfoundland Cancer Treatment and Research Foundation - St. John's
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 598 participants |
| Start Date | 1999-02 |
| Est. Completion | 2006-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003833
The ClinicalTrials.gov registry entry for NCT00003833 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 598 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,510-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (60% lower). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which DNA stability analysis is the first listed.
NCT00003833 reports 20 study locations spanning 7 distinct geographic areas - top geographies include British Columbia, Ontario, New Brunswick.
Frequently Asked Questions
What is clinical trial NCT00003833 about?
NCT00003833 is a clinical study titled "Genetic Study in Patients With Stage II or Stage III Colon Cancer". RATIONALE: Genetic studies may help in understanding the genetic processes that cause some types of cancer. PURPOSE: Genetic trial to study certain genes of patients who have stage II or stage III colon cancer.
What is the current status of trial NCT00003833?
This trial is currently completed. The enrollment target is 598 participants. The study started on 1999-02. Estimated completion is 2006-08.
What conditions does trial NCT00003833 study?
This clinical trial studies the following conditions: Colorectal Cancer.
What interventions are being tested in trial NCT00003833?
The interventions under investigation include: DNA stability analysis (GENETIC), gene mapping (GENETIC).
Who is sponsoring clinical trial NCT00003833?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00003833 being conducted?
This trial has 20 study locations across Minnesota, Alberta, British Columbia, New Brunswick, Newfoundland and Labrador. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.